SRCL on NASDAQ

Stericycle

Logo: Stericycle, Public domain, via Wikimedia Commons5

American waste management company

Stericycle, Inc. is an American compliance company that specializes in collecting and disposing regulated medical waste, such as medical waste and sharps, pharmaceuticals and controlled substances, trace chemotherapy waste, and pathological waste. It also provides related education and training services. The company was founded in 1989 and is headquartered in Bannockburn, Illinois, with more bases of operation around North America and Europe.3 Its shares trade on NASDAQ under the symbol SRCL.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1989Founded1

Compare with Clean Harbors, Perma-Fix Environmental Services or Li-Cycle Holdings Corp., or pick any stock.

  • TickerSRCL on NASDAQ1
  • Industrytertiary sector of the economy1
  • HeadquartersLake Forest1
  • Founded inLake Forest1
  • Websitewww.stericycle.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address2355 Waukegan Road, Bannockburn, Il 600156
  • Filer categoryLarge accelerated filer6
  • LEIB8PTJH2P0AXSWSMP21364
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressCORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 21910144
StericycleTruck
Photo: Raysonho @ Open Grid Scheduler / Grid Engine, CC0, via Wikimedia Commons9

Stericycle, Inc. is an American compliance company that specializes in collecting and disposing regulated medical waste, such as medical waste and sharps, pharmaceuticals and controlled substances, trace chemotherapy waste, and pathological waste. It also provides related education and training services. The company was founded in 1989 and is headquartered in Bannockburn, Illinois, with more bases of operation around North America and Europe.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

38.2%Gross margin10
2.9%Operating margin10
-0.8%Net margin10
-1.7%Revenue growth, 202310
-0.8%Return on equity10
0.51×Debt to equity10
$112.0MFree cash flow10

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue62¢$1.6B
  • Selling, general and admin33¢$873.9M
  • Other costs4¢$116.1M
  • Income tax1¢$24.6M

Out of $2.7B in revenue.10 The company lost money this year.

Where each dollar of operating cash went, fiscal 2023

  • Capital spending54¢$131.3M
  • Kept or used elsewhere46¢$112.0M

Out of $243.3M of cash from operations.10

Financial statements

Revenue1112131410$2.7B in 2023−26% since 2017
0$1.0B$2.0B$3.0B$4.0B2017: $3.6B$3.6B20172018: $3.5B$3.5B2018−3%2019: $3.3B$3.3B2019−5%2020: $2.7B$2.7B2020−19%2021: $2.6B$2.6B2021−1%2022: $2.7B$2.7B2022+2%2023: $2.7B$2.7B2023−2%
Gross profit1112131410$1.0B in 2023−31% since 2017
0$500.0M$1.0B$1.5B2017: $1.5B$1.5B20172018: $1.4B$1.4B2018−6%2019: $1.2B$1.2B2019−15%2020: $1.1B$1.1B2020−10%2021: $1.0B$1.0B2021−3%2022: $1.0B$1.0B2022+1%2023: $1.0B$1.0B2023−1%
Operating income1112131410$77.3M in 2023
-$300.0M-$200.0M-$100.0M0$100.0M$200.0M2017: -$7.6M-$7.6M20172018: -$161.1M-$161.1M2018+2020%2019: -$211.9M-$211.9M2019+32%2020: $31.9M$31.9M20202021: $72.3M$72.3M2021+127%2022: $153.7M$153.7M2022+113%2023: $77.3M$77.3M2023−50%
Net income111210-$21.3M in 2023
-$400.0M-$200.0M0$200.0M2017: $42.4M$42.4M20172018: -$244.7M-$244.7M20182019: -$346.8M-$346.8M2019+42%2020: -$57.3M-$57.3M2020−83%2021: -$26.8M-$26.8M2021−53%2022: $56.5M$56.5M20222023: -$21.3M-$21.3M2023
Fiscal year2017201820192020202120222023
Revenue$3.6B11$3.5B12$3.3B13$2.7B14$2.6B10$2.7B10$2.7B10
Cost of revenue$2.1B18$2.1B12$2.1B13$1.6B14$1.6B10$1.7B10$1.6B10
Gross profit$1.5B11$1.4B12$1.2B13$1.1B14$1.0B10$1.0B10$1.0B10
Selling, general and admin$1.4B11$1.2B12$1.1B13$897.6M14$946.6M10$887.5M10$873.9M10
Operating income-$7.6M11-$161.1M12-$211.9M13$31.9M14$72.3M10$153.7M10$77.3M10
Interest$94.0M19$106.6M19
Income before tax$700.0K10$78.9M10$3.3M10
Income tax-$150.9M11-$29.8M12-$16.8M13-$100.0K14$27.5M10$22.4M10$24.6M10
Net income$42.4M11-$244.7M12-$346.8M12-$57.3M12-$26.8M10$56.5M10-$21.3M10
Earnings per share$0.2711-$2.9112-$3.8113-$0.6314-$0.3010$0.6110-$0.2310
Earnings per share (diluted)$0.2711-$2.9112-$3.8113-$0.6314-$0.3010$0.6110-$0.2310
Shares (weighted, basic)91.8M shares1092.1M shares1092.4M shares10
Shares (weighted, diluted)91.8M shares1092.4M shares1092.4M shares10

Compare Stericycle with another company

Corporate structure

Stericycle sits at the top of its group. 29 entities, 12 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Stericycle

  • Stericycle Wilmington, Delaware, United States
    • Ambimed - Gestao Ambiental, Lda. Subsidiary · Portugal
    • Artech Reduction Technologies Limited Subsidiary · United Kingdom
    • Azormed-Gestao Ambiental, Lda. Subsidiary · Portugal
    • Ecologia y Tecnicas Sanitarias, S.L.U. Subsidiary · Spain
    • Instituto para a Qualidade em Imagem e Proteccao Radiologica, S.A. Subsidiary · Portugal
    • Mobile Shredding Luxembourg Subsidiary · Luxembourg
    • Shred-it Belgium Subsidiary · Belgium
    • Shred-it France Subsidiary · France
    • Shred-it Insurance Limited Subsidiary · Barbados
    • SHRED-IT LIMITED Subsidiary · Manchester, United Kingdom
    • Shred-it Netherlands B.V. Subsidiary · Netherlands
    • Shred-it ROI Limited Subsidiary · Ireland
    • SRCL Consenur CEE, S.A.U. Subsidiary · Spain
    • SRCL Consenur CEE, S.A.U. e Inizia Networks SL UTE Subsidiary · Spain
    • SRCL Consenur S.L.U. Subsidiary · Spain
    • SRCL Ireland Limited Subsidiary · Ireland
    • SRCL LIMITED Subsidiary · Leeds, United Kingdom
    • Stericycle Europe S.a.r.l. Subsidiary · Luxembourg
    • Stericycle International Holdings Canada Limited Subsidiary · United Kingdom
    • Stericycle International Holdings Limited Subsidiary · United Kingdom
    • Stericycle International Limited Subsidiary · United Kingdom
    • Stericycle Management, LLC Subsidiary · Delaware, United States
    • Stericycle of Puerto Rico, Inc. Subsidiary · Puerto Rico, United States
    • Stericycle of Washington, Inc. Subsidiary · Washington, United States
    • Stericycle Panama S de RL Subsidiary · Panama
    • and 3 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Stericycle reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Finance-lease assets$12.8M10 Dec 31, 2023$14.0M10 Dec 31, 2022−8.6%
Operating-lease assets (leased space)$464.3M10 Dec 31, 2023$398.9M10 Dec 31, 2022+16.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$35.3M10 Dec 31, 2023$56.0M10 Dec 31, 2022−37.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$2.8B10 Dec 31, 2023$2.8B10 Dec 31, 2022−1.1%
Intangible assets, net (excluding goodwill)$686.5M10 Dec 31, 2023$811.1M10 Dec 31, 2022−15.4%
Accumulated amortization$925.8M10 Dec 31, 2023$823.3M10 Dec 31, 2022+12.4%

The story

Stericycle was founded in 1989 by Dr. James Sharp based on his business plan to address the Syringe Tide, where hypodermic needles and other medical waste washed up to the shores of New York and New Jersey. The Syringe Tide led to the Medical Waste Tracking Act, signed in 1988, establishing regulated medical waste management as an industry.

In 1992, Mark Miller stepped in as President and CEO, and as a result of Miller's leadership, Stericycle grew rapidly, going public in 1996 on the NASDAQ (ticker SRCL). The company's international business began in 1997 with a joint venture in Mexico. Since then, Stericycle has created services, tools and resources for healthcare professionals not only in the United States and Mexico, but also in Argentina, Brazil, Canada, Chile, Ireland, Japan, Portugal, Puerto Rico, Romania, Spain, and the United Kingdom. In 1999, Stericycle acquired 200,000 customers from Allied Waste Industries after Allied acquired Browning Ferris Industries. Also In 1999, Stericycle began offering safety and medical compliance training services with the launch of its Stericycle Steri-Safe OSHA Compliance program.

Expansion

In the 2000s, Stericycle achieved growth through launching and/or acquiring complementary business lines, as well as continued international expansion. In 2003, Stericycle entered sharps waste management, acquiring Scherer Healthcare's existing practice and occasionally referring to parts of the service as “Bio Systems” in markets like Ireland. In 2004, Stericycle began providing medical waste disposal solutions in the United Kingdom with more international growth following. In 2008, Stericycle acquired its first hazardous waste removal company and in 2010 started its Communications Solutions business line with the acquisition of NotifyMD, among several other acquisitions. The acquisition of PSC Environmental Solutions in 2014 in a deal worth $275 million led to the formal establishment of Stericycle Environmental Solutions focused on hazardous waste. Finally, Stericycle's largest acquisition to date, Shred-it, occurred in 2015, for US$2.3 billion.

The company lost a contract to provide clinical waste services to GPs and pharmacies in Cumbria and north-east England in April 2017, when their competitor, Healthcare Environment Services put in a substantially cheaper offer, of £310,000, than theirs of £479,999. Stericycle then initiated a legal challenge against NHS England’s decision which was dismissed by the High Court of Justice in July 2018, and the company's behaviour severely criticised. Their commercial director Lindsay Dransfield was described as “a broadly unsatisfactory witness”. A confidential settlement was reached in 2019, ending the litigation.

In October 2017, a $295 million settlement was reached on behalf of a nationwide class of Stericycle customers, following a class-action lawsuit accusing the company of engaging in a price-increasing scheme that automatically inflated customers' bills up to 18 percent biannually, according to a news release from Hagens Berman, the Chicago-based law firm that represented the class.

In Spring 2022, Stericycle released the Safeshield antimicrobial medical waste container, which was designed for the storage and transport of regulated medical waste. The continued redesigning of products aims to condense the amount of container types provided by the company from over 150 to less than 20.

In June 2024, Stericycle accepted an offer from WM (formerly Waste Management Inc) to acquire the business for $7.2 billion. The acquisition was completed in November 2024, and the company became a wholly owned subsidiary of WM.

In January 2025 Urbaser completed the acquisition of Stericycle’s biosanitary waste management businesses in Spain and Portugal. The deal, announced in October 2024, has been completed according to the expected timeline.

From Wikipedia’s article on Stericycle, shared under CC BY-SA 4.0.7

Leadership

Who has led Stericycle, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (41)

Products and brands

International operations

Stericycle has a presence in 10 countries. Approximately 10% of the company's revenue comes from its international operations. Full services are offered in the U.S., Canada, Ireland, Spain and Portugal. Stericycle offers all services, except for hazardous waste management, in the United Kingdom. Only secure information destruction services are provided in Austria, Belgium, France, Germany, the Netherlands, and Luxembourg.

Stericycle no longer operates in Argentina, Brazil, Chile, Japan, Mexico, Australia, South Korea, Romania, United Arab Emirates, and Singapore.

Services

Stericycle offers the following types of specialized waste management:

Regulated medical waste management

Read the full text

Hazardous waste management

Sharps waste management

Pharmaceutical waste or environmentally persistent pharmaceutical pollutants

Drug disposal

Integrated Waste Stream services – coordinating multiple waste streams for one entity

Beyond services related to healthcare wastes, in some markets the company has expanded its offerings to include management of certain hazardous wastes as well as patient transport and medical courier services. Stericycle offers secure information destruction, for both paper and hard drive, through Shred-it.

The company also offers compliance training primarily through online courses focused on applying industry regulations related to information security, human resources, medical billing, and other topics. They have also developed training software related to compliance.

During the COVID-19 pandemic, the company managed the transportation, treatment, and disposal of potentially infectious items. The company developed strategies for PPE disposal, including a waste pickup and mailback option. In 2021, Stericycle and UPS partnered through UPS Healthcare, creating a system to manage the reverse logistics of medical waste, including the transportation, treatment, and disposal of waste.

Beginning in 2021, Stericycle has published an annual Healthcare Workplace Safety Trend Report, which analyzes issues within the medical workplace, including comparisons of day-to-day stress on a yearly basis, and the importance of medical waste management.

UK

The company has a contract for collection and disposal services to around 700 GP practices across Hampshire and Isle of Wight, Buckinghamshire, Surrey, Sussex, Oxfordshire and Berkshire and acute NHS trusts in England. In 2020 it suffered from capacity problems and failed to collect clinical waste routinely from 139 practices during September and October. 245 collections were missed. They said that the NHS was producing significantly higher volumes of clinical waste than expected because of the amount of Personal protective equipment being used.

From Wikipedia’s article on Stericycle, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries

Subsidiaries (Exhibit 21)

  • Ambimed - Gestao Ambiental, Lda. Portugal8
  • Artech Reduction Technologies Limited UK8
  • Azormed-Gestao Ambiental, Lda. Portugal8
  • Ecologia y Tecnicas Sanitarias, S.L.U. Spain8
  • Instituto para a Qualidade em Imagem e Proteccao Radiologica, S.A. Portugal8
  • Mobile Shredding Luxembourg Luxembourg8
  • SRCL Consenur CEE, S.A.U. Spain8
  • SRCL Consenur CEE, S.A.U. e Inizia Networks SL UTE Spain8
  • SRCL Consenur S.L.U. Spain8
  • SRCL Ireland Limited Ireland8
  • SRCL Limited Ireland8
  • Shred-it Belgium Belgium8
  • Shred-it France France8
  • Shred-it GmbH Germany8
  • Shred-it Insurance Limited Barbados8
  • Shred-it Limited UK8
  • Shred-it Netherlands B.V. Netherlands8
  • Shred-it ROI Limited Ireland8
  • SteriVentures, LLC Delaware8
  • Stericycle B.V. Netherlands8
  • Stericycle Europe S.a.r.l. Luxembourg8
  • Stericycle International Holdings Canada Limited UK8
  • Stericycle International Holdings Limited UK8
  • Stericycle International Limited UK8
All 31 listed subsidiaries
  • Stericycle International, LLC Delaware8
  • Stericycle Management, LLC Delaware8
  • Stericycle Panama S de RL Panama8
  • Stericycle of Puerto Rico, Inc. Puerto Rico8
  • Stericycle of Washington, Inc. Washington8
  • Stericycle, ULC Canada8
  • Stroud Properties, Inc. Delaware8

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Nov 8, 20248-K Entered a material agreement; Change to shareholders' rights73
  2. Nov 4, 20248-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer74
  3. Nov 1, 20248-K Other events75
  4. Sep 24, 20248-K Other events76
  5. Sep 6, 20248-K Other events77
  6. Aug 14, 20248-K Shareholder vote78
  7. Jun 3, 20248-K Entered a material agreement; Regulation FD disclosure79
  8. May 22, 20248-K Shareholder vote80
  9. Apr 25, 20248-K Results of operations81
  10. Feb 28, 20248-K Results of operations82
  11. Feb 2, 20248-K Debt or obligation accelerated83
  12. Nov 2, 20238-K Results of operations84
  13. May 3, 2019New chief executive Cindy J. Miller becomes CEO20
  14. Feb 22, 2013New chief executive Charles A. Alutto becomes CEO21
  15. Feb 6, 2006New chief executive Mark C. Miller becomes CEO22
  16. Aug 23, 1996Went public Listed on NASDAQ1
  17. 1989Founded Founded in Lake Forest1

Calendar

When it reported results

  1. Apr 25, 2024Reported quarterly or annual results81
  2. Feb 28, 2024Reported quarterly or annual results82
  3. Nov 2, 2023Reported quarterly or annual results84
  4. Jul 27, 2023Reported quarterly or annual results85
  5. Apr 27, 2023Reported quarterly or annual results86
  6. Feb 23, 2023Reported quarterly or annual results87
  7. Nov 3, 2022Reported quarterly or annual results88
  8. Aug 5, 2022Reported quarterly or annual results89

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

292 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 25 major events, 179 insider forms, 24 large holders, 51 other. The latest 20:

  1. May 14, 2025S-8 POS EDGAR
  2. May 14, 2025S-8 POS EDGAR
  3. May 14, 2025S-8 POS EDGAR
  4. May 14, 2025S-8 POS EDGAR
  5. May 14, 2025S-8 POS EDGAR
  6. May 14, 2025S-8 POS EDGAR
  7. Nov 15, 2024SCHEDULE 13G/A EDGAR
  8. Nov 14, 2024EFFECT EDGAR
  9. Nov 14, 2024EFFECT EDGAR
  10. Nov 14, 2024EFFECT EDGAR
  11. Nov 14, 2024EFFECT EDGAR
  12. Nov 14, 2024EFFECT EDGAR
  13. Nov 14, 202415-12G EDGAR
  14. Nov 13, 2024SC 13G STERICYCLE, INC. EDGAR
  15. Nov 12, 2024SC 13G/A SEC SCHEDULE 13G EDGAR
  16. Nov 8, 20248-K EDGAR
  17. Nov 8, 2024SC 13G/A SC 13G/A#2 FOR CCP AND STERICYCLE, INC. EDGAR
  18. Nov 4, 20244 EDGAR
  19. Nov 4, 20244 EDGAR
  20. Nov 4, 20244 EDGAR

The 292 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 7, 2023Reuter Joseph AnthonyEVP & CHIEF PEOPLE OFFICERBuy7,000$44.09$308.6KForm 4
Feb 24, 2023Gursahaney Naren KDirectorBuy6,000$47.91$287.5KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Stericycle is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSTERICYCLE INC2
  • CIK0000861878
  • Employer ID (EIN)36-36404022
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)4955 Hazardous Waste Management2
  • SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance2
  • Business address2355 Waukegan Road, Bannockburn, IL 600152
  • Phone847-367-59102
  • Shares outstanding92,837,446 as of Oct 28, 202417
  • Public float$4.3B as of Jun 30, 202310
  • On EDGAR sinceJun 11, 19962
  • Filings1,770 in all: 4 (981), 8-K (224), 10-Q (85), SC 13G/A (76), 3 (53), UPLOAD (43), CORRESP (38), SC 13G (29)2
    All 51 form types

    10-K (28), DEF 14A (28), DEFA14A (26), S-8 (18), 4/A (16), 8-K/A (15), S-8 POS (11), S-3/A (10), SC 13D/A (8), POS AM (7), EFFECT (6), SC 13D (6), 10-K/A (5), S-1/A (5), 3/A (4), 424B1 (4), PRE 14A (4), S-3 (4), 10-Q/A (3), PX14A6G (3), S-4/A (3), 25-NSE (2), ARS (2), NO ACT (2), NT 10-K (2), S-4 (2), 144 (1), 15-12G (1), 424B2 (1), 424B3 (1), 424B5 (1), 5 (1), 8-A12B (1), 8-A12G (1), CERTNAS (1), DEFM14A (1), FWP (1), PREM14A (1), PRER14A (1), S-1 (1), S-3ASR (1), S-3MEF (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Feb 28, 2024
    Quarterly report (10-Q) Nov 1, 2024
    Proxy statement (DEF 14A) Apr 5, 2024
    Latest 8-K (8-K) Nov 8, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
    SEC EDGAROther events
  76. 76
    SEC EDGAROther events
  77. 77
    SEC EDGAROther events
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97